ECDC is monitoring reports from three countries (France, the United Kingdom and the United States) of cases of invasive meningococcal disease (IMD) associated with travel to the Kingdom of Saudi Arabia (KSA).
On 5 and 6 September, ECDC hosted the first joint SoHO-Net Tissues and Cells (TC) and Medically Assisted Reproduction (MAR) group meeting in Stockholm, Sweden.
Embark on a two-year hands-on training that enables fellows to support prevention, preparedness and surveillance activities, outbreak investigation and control of communicable disease threats across the European Union and European Economic Area (EU/EEA) – and beyond. Apply for the ECDC Fellowship Programme (EPIET/EUPHEM) by 15 October 2023.
In a Threat Assessment Brief released today, the European Centre for Disease Prevention and Control (ECDC) assesses the overall level of risk to the EU/EEA associated with the spread of the Omicron XBB.1.5 SARS-CoV-2 sub-lineage as low for the general population.
XBB.1.5 is a sub-lineage of the SARS-CoV-2 lineage XBB, and is currently estimated to have a large growth advantage over previously circulating lineages in North America (109%) and Europe (113%).
As of 20 January 2022, the Omicron variant has been identified in all EU/EEA countries. From 20 December 2021 to 9 January 2022, there were 23 EU/EEA countries with adequate sequencing volume that reported an estimated prevalence of Omicron VOC of 69.4%.
From 20 December 2021 to 2 January 2022, there were 21 EU/EEA countries with adequate sequencing volume that reported an estimated prevalence of Omicron VOC of 46%.
ECDC has awarded more than 77 M€ to 24 EU/EEA countries to strengthen whole genome sequencing and RT-PCR infrastructures within the countries’ national public health programmes.